A New Milestone for Citi Pharma’s European Expansion

We are proud to announce the signing of a ๐Œ๐ž๐ฆ๐จ๐ซ๐š๐ง๐๐ฎ๐ฆ ๐จ๐Ÿ ๐”๐ง๐๐ž๐ซ๐ฌ๐ญ๐š๐ง๐๐ข๐ง๐  (๐Œ๐จ๐”) ๐›๐ž๐ญ๐ฐ๐ž๐ž๐ง ๐‚๐ข๐ญ๐ข ๐๐ก๐š๐ซ๐ฆ๐š ๐‹๐ข๐ฆ๐ข๐ญ๐ž๐ ๐š๐ง๐ ๐„๐ฑ๐œ๐ž๐ฅ๐ฅ๐ž๐ง๐ญ ๐†๐ฆ๐›๐‡, ๐’๐จ๐ฅ๐ข๐ง๐ ๐ž๐ง, ๐†๐ž๐ซ๐ฆ๐š๐ง๐ฒ โ€” ๐š ๐ค๐ž๐ฒ ๐ฌ๐ญ๐ž๐ฉ ๐ญ๐จ๐ฐ๐š๐ซ๐ ๐ฌ๐ญ๐ซ๐ž๐ง๐ ๐ญ๐ก๐ž๐ง๐ข๐ง๐  ๐จ๐ฎ๐ซ ๐ž๐ฑ๐ฉ๐จ๐ซ๐ญ ๐œ๐š๐ฉ๐š๐›๐ข๐ฅ๐ข๐ญ๐ข๐ž๐ฌ ๐š๐ง๐ ๐ž๐ฑ๐ฉ๐š๐ง๐๐ข๐ง๐  ๐จ๐ฎ๐ซ ๐ฉ๐ซ๐ž๐ฌ๐ž๐ง๐œ๐ž ๐ข๐ง ๐ญ๐ก๐ž ๐„๐ฎ๐ซ๐จ๐ฉ๐ž๐š๐ง ๐ฉ๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ ๐ฆ๐š๐ซ๐ค๐ž๐ญ, in strategic collaboration with Mr. Ashiq, Managing Director, Excellent GmbH.
We were honored to have ๐Œ๐ซ. ๐Œ๐š๐ฎ๐ซ๐ข๐œ๐ž ๐†๐š๐ฃ๐š๐ง, Counsellor / First Secretary (Economic and Political Affairs), Embassy of the Federal Republic of Germany, Islamabad, join us as our Guest of Honor, and to have him ๐—ถ๐—ป๐—ฎ๐˜‚๐—ด๐˜‚๐—ฟ๐—ฎ๐˜๐—ฒ ๐—ผ๐˜‚๐—ฟ ๐—ข๐—ป๐—ฐ๐—ผ๐—น๐—ผ๐—ด๐˜† ๐—ฃ๐—น๐—ฎ๐—ป๐˜ โ€” ๐—ฎ ๐—น๐—ฎ๐—ป๐—ฑ๐—บ๐—ฎ๐—ฟ๐—ธ ๐—บ๐—ผ๐—บ๐—ฒ๐—ป๐˜ ๐—ณ๐—ผ๐—ฟ ๐—–๐—ถ๐˜๐—ถ ๐—ฃ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ’๐˜€ ๐—น๐—ผ๐—ฐ๐—ฎ๐—น ๐—บ๐—ฎ๐—ป๐˜‚๐—ณ๐—ฎ๐—ฐ๐˜๐˜‚๐—ฟ๐—ถ๐—ป๐—ด ๐—ฐ๐—ฎ๐—ฝ๐—ฎ๐—ฏ๐—ถ๐—น๐—ถ๐˜๐—ถ๐—ฒ๐˜€.
We were also honored by the presence of ๐Œ๐ซ. ๐…๐š๐ก๐ž๐ž๐ฆ ๐’๐ž๐ ๐š๐ฅ, President, LCCI; ๐Œ๐ซ. ๐’๐š๐ก๐ข๐ซ ๐‘๐š๐ฌ๐ก๐ž๐ž๐, CEO, Sahir Associates; and ๐€๐ฌ๐ข๐Ÿ ๐’๐ก๐ž๐ข๐ค๐ก, Ibrahim International.
This MoU marks a step toward global growth, increased exports, and a stronger Pakistani pharmaceutical presence in Europe.